These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1960402)

  • 1. A cytotoxicity assay for tumour necrosis factor using a human rhabdomyosarcoma cell line.
    Meager A
    J Immunol Methods; 1991 Nov; 144(1):141-3. PubMed ID: 1960402
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioassay for tumor necrosis factors-alpha and -beta.
    Evans TJ
    Mol Biotechnol; 2000 Jul; 15(3):243-8. PubMed ID: 10986700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor necrosis factor and lymphotoxin: endogenous antineoplastic mediators].
    Ketlinskiĭ SA; Belova LA
    Vopr Onkol; 1990; 36(4):396-402. PubMed ID: 2111959
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphotoxin and TNF differ greatly in capacity to induce differentiation of human myeloblastic leukemia ML-1 cells.
    Takeda K; Iwamoto S; Takeda M
    Biochem Mol Biol Int; 1994 Apr; 32(6):1109-19. PubMed ID: 8061628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive and simple bioassay for human tumour necrosis factor-alpha.
    Blagosklonny MV; Neckers LM
    Eur Cytokine Netw; 1993; 4(4):279-83. PubMed ID: 8268418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour necrosis factor-alpha and lymphotoxin have opposite effects on sympathetic efferent nerves to brown adipose tissue by direct action in the central nervous system.
    Holt SJ; Grimble RF; York DA
    Brain Res; 1989 Sep; 497(1):183-6. PubMed ID: 2790452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice.
    Granger GA; Masunaka I; Averbook B; Kobayashi M; Fitzgerald M; Yamamoto R
    J Biol Response Mod; 1988 Oct; 7(5):488-97. PubMed ID: 3263472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LIGHT, a member of the TNF superfamily, induces morphological changes and delays proliferation in the human rhabdomyosarcoma cell line RD.
    Hikichi Y; Matsui H; Tsuji I; Nishi K; Yamada T; Shintani Y; Onda H
    Biochem Biophys Res Commun; 2001 Dec; 289(3):670-7. PubMed ID: 11726199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Augmentation of TNF- and lymphotoxin-mediated cytotoxic effect in the combined use of ACNU and involvement of oxygen free radicals].
    Matsunaga K; Mashiba H
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):452-8. PubMed ID: 2321976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells.
    Garrett IR; Durie BG; Nedwin GE; Gillespie A; Bringman T; Sabatini M; Bertolini DR; Mundy GR
    N Engl J Med; 1987 Aug; 317(9):526-32. PubMed ID: 3497347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin.
    Stemme S; Fager G; Hansson GK
    Immunology; 1990 Feb; 69(2):243-9. PubMed ID: 2106484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha, but not lymphotoxin, stimulates growth of tumor cells in hairy cell leukemia.
    Buck C; Digel W; Schöniger W; Stefanic M; Ragnavachar A; Heimpel H; Porzsolt F
    Leukemia; 1990 Jun; 4(6):431-4. PubMed ID: 2162999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphotoxin lacks effects on 75-kDa receptors in cytotoxicity on U-937 cells.
    Iwamoto S; Shibuya I; Takeda K; Takeda M
    Biochem Biophys Res Commun; 1994 Feb; 199(1):70-7. PubMed ID: 8123048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphotoxin and tumour necrosis factor as possible mediators of an inflammatory response.
    Ciba Found Symp; 1987; 131():185-91. PubMed ID: 3330010
    [No Abstract]   [Full Text] [Related]  

  • 15. Woodchuck lymphotoxin-alpha, -beta and tumor necrosis factor genes: structure, characterization and biological activity.
    Li DH; Havell EA; Brown CL; Cullen JM
    Gene; 2000 Jan; 242(1-2):295-305. PubMed ID: 10721723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in permeability of human endothelial cell monolayer by recombinant human lymphotoxin.
    Shinjo K; Tsuda S; Hayami T; Asahi T; Kawaharada H
    Biochem Biophys Res Commun; 1989 Aug; 162(3):1431-7. PubMed ID: 2788411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ligand binding and antiproliferative effects of tumor necrosis factor and lymphotoxin by soluble forms of recombinant P60 and P80 receptors.
    Higuchi M; Aggarwal BB
    Biochem Biophys Res Commun; 1992 Jan; 182(2):638-43. PubMed ID: 1310388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
    Browning J; Ribolini A
    J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragmentation of cellular DNA is a nonspecific indicator of responsiveness to tumor necrosis factor.
    Rubin BY; Anderson SL; Lunn RM; Hellermann GR; Smith LJ
    J Biol Response Mod; 1989 Oct; 8(5):553-9. PubMed ID: 2507749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipases are activated during cell destruction by human alpha-lymphotoxin in vitro.
    Fitzgerald MT; Longmuir KJ; Granger GA
    Lymphokine Res; 1987; 6(4):319-24. PubMed ID: 3501507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.